PEER - Evidence Summaries - Guidelines

CFPCLearn’s primary care focused library includes a variety of content including evidence summaries, videos, podcasts and interactive learning courses to support clinicians in their practice.

Most Recent Tools for Practice

Tools for Practice #383 – A single dose for treating yeast infections: Is it really this simple?

Does route or duration of antifungals matter when treating uncomplicated vulvovaginal candidiasis in non-pregnant women?

Route and duration do not impact efficacy; only a single dose of oral fluconazole or intravaginal antifungal (example clotrimazole) is needed. Patient preference should guide treatment choice. Read More

18 February 2025

Tools for Practice #382 – Exercise for Parkinson’s Disease: More movement = Better movement?

How effective is exercise in Parkinson’s disease?

In patients with Parkinson’s Disease, exercise results in clinically meaningful improvements in motor symptoms similar to changes seen with medications (4-9 points better on a 108-point scale) compared to control over 1-6 months. It doesn’t provide clear improvements in quality of life. Six more patients out of 100 who exercise will avoid one or more falls over 6-12 months compared to control. Read More

3 February 2025

Tools for Practice #381 – Pharm for Fibro, Round 2: Can gabapentinoids ease the pain?

Do gabapentinoids reduce pain in patients with fibromyalgia?

About 40% of people with fibromyalgia on pregabalin 300-600mg/day experience a meaningful reduction in pain (pain reduced by ≥30%) versus 30% on placebo at 8-14 weeks. Lower doses (example: 150mg) may not be effective; however, higher doses cause more harm, with up to ~30% of people stopping due to side effects (versus 10% on placebo). Based on one small randomized, controlled trial (RCT), gabapentin is also effective. Read More

20 January 2025

Tools for Practice #380 Is the secret to treating depression hidden in your genes?

Can genetic testing improve the efficacy and safety of antidepressants?

Pharmacogenomics testing to guide treatment in patients with depression might increase response and remission rates at 8 weeks by about 5% (example response rate 29% with pharmacogenomics versus 25% usual care), with no clear effects on tolerability. Studies have significant limitations. Cost (up to > $2000) and genes tested vary widely. Read More

3 January 2025

Tools for Practice #379 Bumpin’ Up the Protection? RSV Vaccine in Pregnancy

How effective and safe is the respiratory syncytial virus (RSV) vaccine (AbrysvoTM) when given during pregnancy?

The RSV vaccine (AbrysvoTM), approved by Health Canada in pregnancy, reduces severe RSV infections (0.5% infection rate versus 1.8% placebo) and RSV hospitalizations (0.5% versus 1.3%) at 180 days in infants. Preterm births were numerically, but not statistically, higher with this vaccine versus placebo. Administration is limited to 32-36 weeks’ gestation to mitigate this potential risk. Guidelines recommend nirsevimab for infants over prenatal vaccine where indicated. Read More

9 December 2024

Congratulations to PEER's Tina Korownyk: Alberta Family Physician of the Year

PEER Director, Dr. Tina Korownyk was awarded the 2023 Alberta Family Physician of the year at the annual Family Medicine Forum gala in Montreal, Quebec on November 10. The PEER team joined Tina to celebrate her achievement as a wonderful physician and leader in primary care. Congratulations Tina!

PEER Values

When creating primary care education and programs, the PEER team focuses on minimizing bias, patient orientated outcomes, shared decision making, collaboration and most importantly simplicity.

Who is PEER?

Patients, Experience, Evidence and Research (PEER) was formed between a group of primary care providers who shared a common belief that evidence should be made accessible to all primary care providers.

Empowering Primary Care Through Evidence

PEIP Conference 2025 Dates Announced.

Most Recent Tools for Practice

Tools for Practice #383 – A single dose for treating yeast infections: Is it really this simple?

Tools for Practice #382 – Exercise for Parkinson’s Disease: More movement = Better movement?

Tools for Practice #381 – Pharm for Fibro, Round 2: Can gabapentinoids ease the pain?

Tools for Practice #380 Is the secret to treating depression hidden in your genes?

Tools for Practice #379 Bumpin’ Up the Protection? RSV Vaccine in Pregnancy

Congratulations to PEER's Tina Korownyk: Alberta Family Physician of the Year

PEER Values

Who is PEER?

Follow @peerevidence on Instagram

Our Partners

Questions?

Copyright © 2025 PEER. All rights reserved.

Sign Up for the PEER Newsletter